StonvexLoading…
StonvexStonvexStonvexCore line items from AVTX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $59.00K | $441.00K | $1.92M | $18.05M |
Operating Income | $-72.92M | $-68.51M | $-27.35M | $-37.44M |
Net Income | $-78.26M | $-35.13M | $-31.54M | $-41.66M |
EPS (Diluted) | $-5.84 | $-20.91 | $-113.58 | $-1063.00 |
Total Assets | $116.46M | $150.73M | $20.99M | $33.37M |
Total Liabilities | $33.41M | $17.70M | $13.69M | $44.28M |
Cash & Equivalents | $15.86M | $134.55M | $7.42M | $13.17M |
Free Cash Flow OCF − CapEx | Not available | $-49.06M | $-30.84M | $-26.85M |
Shares Outstanding | 18.51M | 10.47M | 801.75K | 39.29K |